baber/WOPTO huggingface dataset:
Patent DK-0528859-T3 (DK)
Inventor: PANG GERALD TOH
IPC: A61K39/12
Filed: 1991-04-24
Granted: 1998-09-14
Abstract: PCT No. PCT/AU91/00159 Sec. 371 Date Oct. 23, 1992 Sec. 102(e) Date Oct. 23, 1992 PCT Filed Apr. 24, 1991 PCT Pub. No. WO91/16073 PCT Pub. Date Oct. 31, 1991Red blood cells or derivatives thereof such as ghost preparations can act as a potent carrier for orally administered antigens. Mucosal immunity in particular can be effectively induced against such viruses as influenza when adsorbed to chicken red blood cells and orally administered.
Patent DK-0485577-T3 (DK)
Inventor: NEWAY TSEHAY
IPC: A61K39/00
Filed: 1991-06-06
Granted: 1996-01-15
Abstract: PCT No. PCT/FR91/00449 Sec. 371 Date Apr. 3, 1992 Sec. 102(e) Date Apr. 3, 1992 PCT Filed Jun. 6, 1991 PCT Pub. No. WO91/18617 PCT Pub. Date Dec. 12, 1991.A pharmaceutical composition having as the active ingredient an at least partially purified extraction fraction of polar glycopeptidolipids of Mycobacterium chelonae having formula (1). The composition can be used in particular for stimulating non-specific immunity in humans and animals.
Patent DK-0547126-T3 (DK)
Inventor: KLAVENESS JO
IPC: A61K31/765
Filed: 1991-09-07
Granted: 1996-03-18
Abstract: The present invention relates to the process for the preparation of a biodegradable polymer comprising diester units of the formula (III)-[(O)-CO-O-C(R1R2)-O-CO-(O)-R3]-;where R1 and R2 each represents a hydrogen atom or a carbon-attached monovalent organic group or R1 and R2 together form a carbon-attached divalent organic group; m and n, which may be the same or different, are 0 or 1; and R3 is a carbon-attached divalent organic grouping.
Patent DK-0533210-T3 (DK)
Inventor: EIBL JOHANN
IPC: A61K38/17
Filed: 1991-01-28
Granted: 1997-11-03
Abstract: The use of opt. activated protein C (I) to prepare a compsn. for normalising increased vascular permeabilty and to inhibit permeability defects of the vascular wall is new. Also new is the use of (I) to prepare a compsn. for stimulating the beta-adrenergic receptors.
Patent DK-0588833-T3 (DK)
Inventor: OLLERENSHAW ROBERT CHARLES A W
IPC: C10B53/02
Filed: 1992-05-29
Granted: 1996-08-05
Abstract: PCT No. PCT/GB92/00974 Sec. 371 Date Mar. 29, 1994 Sec. 102(e) Date Mar. 29, 1994 PCT Filed May 29, 1992 PCT Pub. No. WO92/21735 PCT Pub. Date Dec. 10, 1992A method of treating biomass material e.g. straw, comprises heating the biomass material to a treatment temperature below a temperature at which the material would undergo combustion, washing the biomass material, and partially redrying the washed material thereby to produce a material which may be used as a substitute for peat.
Patent DK-0591392-T3 (DK)
Inventor: RON EYAL
IPC: A61K38/18
Filed: 1992-06-22
Granted: 1996-09-30
Abstract: PCT No. PCT/US92/05309 Sec. 371 Date Jun. 29, 1993 Sec. 102(e) Date Jun. 29, 1993 PCT Filed Jun. 22, 1992 PCT Pub. No. WO93/00050 PCT Pub. Date Jan. 7, 1993A composition comprising a pharmaceutically acceptable admixture of an osteogenic protein; a polymer matrix component selected from the group consisting of poly(lactic acid), poly(glycolic acid), and copolymers of lactic acid and glycolic acid; and an osteogenic protein-sequestering material.
Patent DK-0583421-T3 (DK)
Inventor: HALLINAN E ANN
IPC: A61P13/00
Filed: 1992-04-16
Granted: 1999-11-22
Abstract: The present invention provides dibenzoxazepine compounds of Formula I: <CHEM> which are useful as analgesic agents for the treatment of pain, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, and a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
Patent DK-0598834-T3 (DK)
Inventor: DESMARAIS THOMAS ALLEN
IPC: B01F7/00
Filed: 1992-08-07
Granted: 1997-07-07
Abstract: Disclosed is a process for the continuous preparation of high internal phase emulsions which are suitable for subsequent polymerization into polymeric foam materials that, upon dewatering, act as absorbents for aqueous body fluids. The process involves continuous introduction of a certain type of monomer-containing oil phase and a certain type of electrolyte-containing water phase into a dynamic mixing zone at relatively low water to oil phase ratios. Flow rates are then steadily adjusted to increase the water to oil ratio of the streams fed to the dynamic mixing zone while subjecting the dynamic mixing zone contents to shear agitation which is sufficient to thereby form a high internal phase emulsion that, upon subsequent polymerization, provides a foam having an average cell size of from about 5 to 100 microns. The formation of such a stable high internal phase emulsion is completed by feeding the contents of the dynamic mixing zone to and through a static mixing zone.
Patent DK-0582977-T3 (DK)
Inventor: SOBOTTA RAINER DR
IPC: C07D209/34
Filed: 1993-08-06
Granted: 1996-12-16
Abstract: The present invention relates to an improved process for the preparation of 1,3-dialkyl-5-hydroxyindoles and their etherified derivatives. <IMAGE>
Patent DK-0650473-T3 (DK)
Inventor: JIMBOW KOWICHI
IPC: C07C323/41
Filed: 1993-07-14
Granted: 1997-08-25
Abstract: PCT No. PCT/CA93/00292 Sec. 371 Date Mar. 15, 1995 Sec. 102(e) Date Mar. 15, 1995 PCT Filed Jul. 14, 1993 PCT Pub. No. WO94/02456 PCT Pub. Date Feb. 3, 1994Compounds useful in radioimaging and radiochemotherapy as it particularly relates to the treatment and location of malignant melanomas and other pigmenting disorders, as well as novel acyl derivatives of phenolic thioester amines and their use in compositions for blocking melanin synthesis in human or animal melanocyte cells.
Patent DK-0667799-T3 (DK)
Inventor: ELLINGSEN OLAV
IPC: C10G9/00
Filed: 1993-10-04
Granted: 1998-02-23
Abstract: PCT No. PCT/NO93/00148 Sec. 371 Date Mar. 27, 1995 Sec. 102(e) Date Mar. 27, 1995 PCT Filed Oct. 4, 1993 PCT Pub. No. WO94/08680 PCT Pub. Date Apr. 28, 1994An apparatus and method for separating the components of and/or decomposing a liquid material, involving the application of an artificial gravitational field to a liquid material by rotating the liquid material in a rotatable vessel. A non-rotatable mechanical member contacts the liquid material while the liquid material is exposed to the artificial gravitational field. The liquid material is thusly subjected to thermomechanical frictional heating.
Patent DK-0622420-T3 (DK)
Inventor: SOLDAT ANDRE
IPC: C09J7/02
Filed: 1994-04-27
Granted: 2002-10-28
Abstract: Acetylenic alcohol which is an inhibitor of hydrosilylation reactions, of formula  R - (R') C (OH) - C  IDENTICAL  CH     (I> where     . R is a linear or branched alkyl radical, or a phenyl radical;   . R' is H or R; it being possible for the radicals R and R' and the carbon atom located  alpha  to the triple bond optionally to form a ring; the total number of carbon atoms contained in R and R' being at least 9. Its use as a hydrosilylation inhibitor in curable compositions based on an oil based on silicone containing alkenyl functional groups and/or on an adhesion modifier resin containing SiAlkenyl functional groups, optionally on an adhesion modifier resin containing SiH functional groups, on a silicone crosslinking agent containing SiH functional groups and on a hydrosilylation catalyst.
Patent DK-0693547-T3 (DK)
Inventor: BERTHOLET RAYMOND
IPC: A23L3/3526
Filed: 1995-07-10
Granted: 2001-03-05
Abstract: The invention relates to an antioxidant composition comprising from 20 to 60% wt of complex lipids and from 10 to 75% wt of carboxylic acids 5-hydroxytryptamides (5-HT) from spent ground coffee oil, in which the 5-HT are for example those of behenic, arachidic and/or lignoceric acids, and the complex lipids are phospholipids and glycolipids. This composition may be advantageously used in food products.
Patent DK-0734698-T3 (DK)
IPC: A61F2/06
Filed: 1996-03-28
Granted: 1999-06-23
Abstract: For transluminal implantation in hollow organs, such as blood vessels, urethra etc., a stent comprises a tubular body (1) which can be put in an expanded state and has apertures (3,4) in both longitudinal and circumferential directions to ensure expansion. Each aperture has at least one section (3',3",3"') which is positioned at an angle to the longitudinal axis in both compressed and expanded state. The apertures form slot-like openings with several, partic. three sections which are inclined to the longitudinal axis. The apertures may be zig-zag shaped, Z-shaped, S-shaped or partic. sinusoidal. The body is pref. of memory metal, partic. Nitinol, and/or body-compatible plastic, partic. PE, PA, or PUR elastomer.
Patent DK-0822816-T3 (DK)
Inventor: KATZ BRUCE E
IPC: A61K31/60
Filed: 1996-04-10
Granted: 2001-11-12
Abstract: A composition for the treatment of actinic keratoses includes 5-fluorouracil and an alpha hydroxy carboxylic acid. The composition may further include ancillary ingredients. A therapeutic method involving the composition and a kit for carrying out the treatment are also disclosed.
Patent DK-0851933-T3 (DK)
Inventor: SLABAS ANTONI RYSZARD
IPC: A01H5/00
Filed: 1996-08-06
Granted: 2005-01-17
Abstract: PCT No. PCT/GB96/01894 Sec. 371 Date Jan. 20, 1998 Sec. 102(e) Date Jan. 20, 1998 PCT Filed Aug. 6, 1996 PCT Pub. No. WO97/07222 PCT Pub. Date Feb. 27, 1997The capacity of a plant to produce fatty acids is modulated by controlling the expression of a gene specifying the acetyl CoA carboxylase biotin carboxyl carrier protein. Modulation may comprise increasing the expression of the gene by insertion of additional copies into the genome or inhibiting expression by insertion of an antisense or cosuppression vector directed against the endogenous gene.
Patent DK-0907631-T3 (DK)
Inventor: MOE SCOTT T
IPC: A61P19/00
Filed: 1997-04-30
Granted: 2003-09-22
Abstract: The present invention features compounds able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders using such compounds. Preferred compounds can mimic or block the effect of extracellular calcium on a cell surface calcium receptor.
Patent DK-0914203-T3 (DK)
Inventor: CHRISTENSEN HENRIK
IPC: F01N3/01
Filed: 1997-05-20
Granted: 2001-07-23
Abstract: A method and a reactor for electrochemical conversion of a material (21) being insoluble in a fluid into a material being soluble in the fluid, which method comprises that a flow of the fluid is passed to a reaction zone which comprises an internal circuit consisting of: one or more working electrodes (12), one or more counter-electrodes (13), and one or more ion-selective electrolytes (11), and which internal circuit is applied with an electrical voltage difference sufficient for the electrochemical processes; and use thereof for removal of soot particles from flue gasses and removal of oil in waste water.
Patent DK-0896072-T3 (DK)
Inventor: CHESSERET LAURENT
IPC: C22C38/00
Filed: 1998-07-09
Granted: 2003-03-24
Abstract: A low nickel content austenitic stainless steel has the composition (by wt.) less than 0.1% C, 0.1-1% (exclusive) Si, 5-9% (exclusive) Mn, 0.1-2% (exclusive) Ni, 13-19% (exclusive) Cr, 1-4% (exclusive) Cu, 0.1-0.40% (exclusive) N, 5 x 10<-4>-50 x 10<-4>% (exclusive) B, less than 0.05% P and less than 0.01% S. Preferably, both the ferrite index (IF1) and the martensite stability index (IS) are less than 20, where IF1 = 0.034 x x<2> + 0.284 x x - 0.347 and IS = 0.0267 x y<2> + 0.4332 x y - 3.1459, in which x = 6.903 x Ä-6.998 + Cr% - 0.972 x (Ni% + 20.04C% + 21.31N% + 0.46Cu% + 0.08Mn%)Ü and y = 250.4 - 205.4C% - 101.4N% - 7.6Mn% - 12.1Ni% - 6.1Cr% - 13.3Cu%.
Patent DK-0985032-T3 (DK)
Inventor: TAUSSIG MICHAEL JOHN
IPC: C12Q1/68
Filed: 1998-05-28
Granted: 2004-02-02
Abstract: The invention provides a method of displaying nascent proteins or peptides as complexes with eukaryotic ribosomes and the mRNA encoding the protein or peptide following transcription and translation in vitro, of further selecting complexes carrying a particular nascent protein or peptide by means of binding to a ligand, antigen or antibody, and of subsequently recovering the genetic information encoding the protein or peptide from the selected ribosome complex by reverse transcription and polymerase chain reaction (RT-PCR). The RT-PCR recovery step is carried out directly on the intact ribosome complex, without prior dissociation to release the mRNA, thus contributing to maximal efficiency and sensitivity. The steps of display, selection and recovery can be repeated in consecutive cycles. The method is exemplified using single-chain antibody constructs as antibody-ribosome-mRNA complexes (ARMs).
Patent DK-0991649-T3 (DK)
Inventor: STOKBROEKX RAYMOND ANTOINE
IPC: C07D417/04
Filed: 1998-06-22
Granted: 2003-07-21
Abstract: This invention concerns compounds of formula (I), the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein R<1> is hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, amino, mono- or di(C1-6alkyl)amino, Ar<1>, Ar<1>-NH-, C3-6cycloalkyl, hydroxymethyl or benzyloxymethyl; R<2> and R<3> are hydrogen, or taken together may form a bivalent radical of formula -CH=CH-CH=CH-; R<4>, R<5> and R<6> are each independently selected from hydrogen, halo, C1-6alkyl, C1-6alkyloxy, trifluoromethyl, nitro, amino, cyano, azido, C1-6alkyloxyC1-6alkyl, C1-6alkylthio, C1-6alkyloxycarbonyl or Het<1>; or when R<4> and R<5> are adjacent to each other they may be taken together to form a radical of formula -CH=CH-CH=CH-; A is a bivalent radical of formula NR<7>, NR<7>-Alk<1>-X-, NR<7>-Alk<1>-X-Alk<2>-, O-Alk<1>-X-, O-Alk<1>-X-Alk<2>- or S-Alk<1>-X-; wherein X is a direct bond, -O-, -S-, C=O, -NR<8>- or Het<2>; R<7> is hydrogen, C1-6alkyl or Ar<2>methyl; R<8> is hydrogen, C1-6alkyl or Ar<2>methyl; Alk<1> is C1-6alkanediyl; Alk<2> is C1-4alkanediyl; Ar<1> and Ar<2> are optionally substituted phenyl; phenyl; Het<1> and Het<2> are optionally substituted heterocycles; having angiogenesis inhibiting activity; their preparation, compositions containing them and their use as a medicine.
Patent DK-1033972-T3 (DK)
Inventor: EDWARDS KATARINA
IPC: A61K47/48
Filed: 1998-12-04
Granted: 2003-12-22
Abstract: The present invention relates to a drug delivery system with two-step targeting, which comprises a combination: (a) a lipid carrier provided with cell targeting agent(s) to target the drug delivery system to specific cells or tissues; and (b) a drug enclosed in said lipid carrier and provided with a DNA targeting agent to target the drug to the nuclei of specific target cells. Furthermore, the invention relates to a method of cancer therapy in which the above drug delivery system is administered to a cancer patient. The goal is to treat or analyse both large tumour masses as well as small tumour cell clusters and single spread tumour cells. According to the invention, drug uptake in tumours will be markedly increased at the same time as the interaction of the drug with healthy organs and tissues can be minimized. The invention gives potential to convert palliative into curative treatment.
Patent DK-0998093-T3 (DK)
Inventor: SCHINDLER PROF DR SIGRAM
IPC: H04L12/64
Filed: 1999-10-15
Granted: 2003-07-14
Abstract: The switch (5) recognizes whether control signal for network management, is present for transmitting the backward channel data between the server and the terminal (1), during every communication establishment between server and terminal. The data is transferred only when it is recognized that control signal for network management is recognized.
Patent DK-0970533-T3 (DK)
Inventor: PAUL JEFFREY A
IPC: H01Q21/00
Filed: 1999-01-13
Granted: 2005-11-07
Abstract: An inverted boxhorn antenna array comprising a power divider that is constructed from a single metal piece and a flat metal sheet that is fastened to a rear surface of the power divider. The power divider is fabricated using a variety of waveguide junctions coupled between substantially identical inverted boxhorn subarrays. The junctions includes a central magic tee junction for coupling energy from an input port into the power divider. Alternating folded shunt and folded series tee junctions are used to transfer power coupled by way of the central series junction to the inverted boxhorn subarrays. Specially dimensioned folded shunt and series tee junctions are used in the inverted boxhorn subarrays. Waveguide matched loads are bonded in waveguides between each of the inverted boxhorn radiators of the subarrays. A fully functional antenna assembly includes a radome cover, a quadrature correction plate 18a, and a twist polarizer disposed in front of radiating elements of the inverted boxhorn antenna array.
Patent DK-1077636-T3 (DK)
Inventor: BERNER BRET
IPC: A61B5/1477
Filed: 1999-05-11
Granted: 2004-05-24
Abstract: A method is provided for continually or continuously measuring the concentration of target chemical analytes present in a biological system, and processing analyte-specific signals to obtain a measurement value that is closely correlated with the concentration of the target chemical analyte in the biological system. One important application of the invention involves a method for signal processing in a system for monitoring blood glucose values.
Patent DK-1078006-T3 (DK)
Inventor: FONG SHERMAN
IPC: A61P1/16
Filed: 1999-05-12
Granted: 2009-06-02
Abstract: The present invention encompasses methods and compositions useful in diagnosing and treating hepatic disorders, especially those characterized by inflammation. The method comprises administration of an agent which prevents the interaction of MAdCAM with a MAdCAM binding partner or ligand. These compositions are useful in treating diseases or disorders involving  alpha 4 beta 7/MAdCAM blockade, as well as inhibiting a primary event in the inflammatory response such as blocking interactions between intercellular adhesion molecules and their ligands. Disorders treatable using the methods disclosed herein include infections, especially viral infections, iatrogenic disorders, cholestatic disorders, hereditary disorders, sarcoidosis, organ transplant, and the like. The diagnostic methods of the invention can be employed to detect the presence of a disorder or to monitor the course of therapy used to treat the disorder.
Patent DK-1144932-T3 (DK)
Inventor: CHEN MICHAEL M
IPC: F28D19/04
Filed: 1999-05-27
Granted: 2004-07-19
Abstract: The thermal performance of the heat transfer element assemblies for rotary regenerative air preheaters is optimized to provide a desired level of heat transfer and pressure drop with a reduced volume and weight. The heat transfer plates in the assemblies have notches for maintaining plate spacing and oblique undulations between the notches. The undulations on adjacent plates extend at opposite oblique angles. The ratio of the openings of the undulations to the openings of the notches is greater than 0.3 and less than 0.5. The pitch (spacing) of the notches is greater than two inches and the angle of the undulations with respect to the notches is greater than 20 DEG  and less than 40 DEG .
Patent ES-2257982-T3 (ES)
Inventor: STOLLBURGES MARTIN
IPC: H01R4/48
Filed: 2000-03-04
Granted: 2006-08-16
Abstract: The bridge has two stacked current rails, one with a plug opening and the other with a terminal peg, two elongated adjacent spring contacts (1) fixed together at one end (2) and movable spring elastically at the other end (5), an upper contact zone in the central region of the spring contacts and a lower contact zone near the second end section. The spring contacts are offset near the contact zones to increase their separation. Independent claims are also included for the following: an electrical ganged terminal.
Patent ES-2219221-T3 (ES)
Inventor: SCHMITT KARL-HEINZ
IPC: E01F15/04
Filed: 2000-05-09
Granted: 2004-12-01
Abstract: The system for anchoring the posts (3) of a crash barrier along the roadway (2) of a bridge comprises a retaining plate (18) mounted on the base of each post which fits over a section of the bridge support structure. The retaining plate has a central slot (20), at right angles to the road direction, into which the post fits and lateral strips (21) which fit over the bridge structure.
Patent ES-2208201-T3 (ES)
Title: Composicion de un catalizador para la preparacion de una resina de poliuretano y procedimiento para la preparacion de una resina de poliuretano.
Inventor: TAMANO YUTAKA
IPC: C08G18/66
Filed: 2000-10-10
Granted: 2004-06-16
Abstract: Una composición de catalizador para la producción de una resina de poliuretano que comprende un compuesto de amina representado por la siguiente fórmula (1): R1-N-R3-NH2 (1) R2 donde cada R1 y R2, que son independientes entre sí es un grupo alquilo de C1-4, como por ejemplo grupos alquilo unidos entre sí directamente o a través de un átomo de nitrógeno o un átomo de oxígeno para formar una estructura de anillo, un grupo dimetilaminopropilo o un grupo dietilamino propilo, y R3 es un grupo alquileno de cadena lineal o cadena ramificada de C2-16, y un compuesto de amina representado por la siguiente fórmula (2): R4 (R7-O)n-R7-OH-N-R6-N (2)-R5 (R7-O)n-R7-OH en la que cada R4 y R5 que son independientes entre sí, es un grupo alquilo de C1-4, como por ejemplo grupos alquilo unidos entre sí directamente o a través de un átomo de nitrógeno o un átomo de oxígeno para formar una estructura de anillo, un grupo dimetilaminopropilo o un grupo dietilaminopropilo, R6 es un grupo alquileno de cadena linealo cadena ramificada de C2-16, R7 es un grupo alquileno de cadena lineal o cadena ramificada de C2-3.
Patent ES-2293882-T3 (ES)
Inventor: GLUCK ANTON
IPC: H01H13/02
Filed: 2000-10-18
Granted: 2008-04-01
Abstract: Slot unit housing (12) contains circuit board with push button and connector for reader unit circuit board. Housing has openings (20) to take up actuation section (22) of push buttons, made of transparent plastic. Buttons have prismatic section with entrance surface directed towards LED light source and deflecting surface directed to actuation section so light is emitted through the button.
Patent ES-2220328-T3 (ES)
Inventor: WECHS FRIEDBERT
IPC: B01D69/02
Filed: 2000-12-08
Granted: 2004-12-16
Abstract: Hydrophilic membrane comprises a synthetic polymer and an additive which is a copolymer of vinylpyrrolidone (I) and a vinylimidazole compound (II). An Independent claim is also included for production of the membrane which comprises preparing a solution containing the synthetic polymer, forming the solution into a membrane, precipitating the polymer by heat or with a non-solvent, and washing and drying the membrane and optionally treating it with a wetting agent. The additive is added to the polymer solution before or after forming the membrane.
Patent ES-2202005-T3 (ES)
Title: Metodo y dispositivo para formar una capa de refuerzo de una cubierta.
Inventor: OGAWA YUICHIRO
IPC: B29D30/10
Filed: 2000-04-19
Granted: 2004-04-01
Abstract: Método para formar una capa de refuerzo de una cubierta, en cuyo método una tira continua (3) de un material de refuerzo que comprende una pluralidad de hilos individuales o hilos retorcidos es cortada para así formar a partir de la misma elementos de refuerzo (37) que tienen una longitud predeterminada, y los elementos de refuerzo (37) son unidos cada uno a toda una superficie circunferencial exterior de un elemento de caucho (2a) soportado por un mandril rígido (2) que está siendo sometido a un movimiento de división angular en torno a su eje central, comprendiendo dicho método los pasos de: aportar sucesivamente los elementos de refuerzo (37) a la superficie circunferencial exterior del mandril (2) desde un lado del mismo, en sincronismo con el movimiento de división del mandril (2); y aplicar a presión los respectivos elementos de refuerzo (37) contra la superficie circunferencial exterior del elemento de caucho (2a) a lo largo de la dirección longitudinal de los mismos y unir con elloprogresivamente a presión los elementos de refuerzo (37) al elemento de caucho (2a).